University Hospital Heidelberg
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Private
- Established
- 1388-01-01
- Employees
- -
- Market Cap
- -
Neoadjuvant Irradiation of Retroperitoneal Soft Tissue Sarcoma With Ions Retro-Ion
Not Applicable
Recruiting
- Conditions
- Sarcoma,Soft Tissue
- Interventions
- Radiation: Proton radiationRadiation: Carbon Ion radiation
- First Posted Date
- 2020-01-06
- Last Posted Date
- 2024-01-05
- Lead Sponsor
- University Hospital Heidelberg
- Target Recruit Count
- 64
- Registration Number
- NCT04219202
- Locations
- 🇩🇪
University Hospital of Heidelberg, Radiation Oncology, Heidelberg, Germany
Pancreatic Cancer and Carbon Ion Radiotherapy
Not Applicable
Active, not recruiting
- Conditions
- Pancreatic Cancer
- Interventions
- Radiation: Carbon Ion
- First Posted Date
- 2019-12-11
- Last Posted Date
- 2025-02-20
- Lead Sponsor
- University Hospital Heidelberg
- Target Recruit Count
- 25
- Registration Number
- NCT04194268
- Locations
- 🇩🇪
University Hopsital Heidelberg, Heidelberg, Germany
Carbon Ion Re-Radiotherapy in Patients With Recurrent or Progressive Locally Advanced Head-and-Neck Cancer
Not Applicable
Recruiting
- Conditions
- Locally Advanced Head-and-Neck Cancer
- Interventions
- Radiation: C12 re-irradiationRadiation: Photon re-irradiation
- First Posted Date
- 2019-12-04
- Last Posted Date
- 2024-01-05
- Lead Sponsor
- University Hospital Heidelberg
- Target Recruit Count
- 72
- Registration Number
- NCT04185974
- Locations
- 🇩🇪
University Hospital of Heidelberg, Radiation Oncology, Heidelberg, Germany
Strengthening Primary Healthcare Delivery for Diabetes and Hypertension in Eswatini
Not Applicable
Completed
- Conditions
- Diabetes MellitusHypertension
- Interventions
- Other: CDPOther: DSD
- First Posted Date
- 2019-12-03
- Last Posted Date
- 2024-10-31
- Lead Sponsor
- University Hospital Heidelberg
- Target Recruit Count
- 3500
- Registration Number
- NCT04183413
- Locations
- 🇸🇿
Clinton Health Access Initiative, Mbabane, Swaziland
TEAM-Trial: Targeting Epigenetic Therapy Resistance in AML With Bortezomib
Phase 2
Completed
- Conditions
- Acute Myeloid Leukemia
- Interventions
- First Posted Date
- 2019-11-22
- Last Posted Date
- 2023-03-27
- Lead Sponsor
- University Hospital Heidelberg
- Target Recruit Count
- 50
- Registration Number
- NCT04173585
- Locations
- 🇩🇪
University Hospital Heidelberg, Internal Medicine V, Heidelberg, Baden-Württemberg, Germany
Clinical Performance of Long-span Fixed Partial Dentures
Not Applicable
Recruiting
- Conditions
- Partial Edentulism
- Interventions
- Device: Completely veneered CoCr fixed partial dentureDevice: Monolithic / facially veneered zirconia fixed partial denture
- First Posted Date
- 2019-11-18
- Last Posted Date
- 2023-05-09
- Lead Sponsor
- University Hospital Heidelberg
- Target Recruit Count
- 40
- Registration Number
- NCT04166695
- Locations
- 🇩🇪
Department of Prosthodontics, University Hospital Heidelberg, University of Heidelberg, Heidelberg, Baden-Württemberg, Germany
Nivolumab/Ipilimumab in Second Line CUP-syndrome
Phase 2
- Conditions
- Cancer of Unknown Primary Site
- Interventions
- Biological: Nivolumab/Ipilimumab
- First Posted Date
- 2019-10-18
- Last Posted Date
- 2020-04-15
- Lead Sponsor
- University Hospital Heidelberg
- Target Recruit Count
- 194
- Registration Number
- NCT04131621
- Locations
- 🇩🇪
University of Heidelberg, Heidelberg, Germany
Gemtuzumab Ozogamicin in Induction and Glasdegib in Postremission Therapy in Patients With AML (Acute Myeloid Leukemia)
Phase 3
Terminated
- Conditions
- Acute Myeloid Leukemia
- Interventions
- Drug: Gemtuzumab Ozogamicin 147Drug: Gemtuzumab Ozogamicin 1Drug: Placebo Oral Tablet
- First Posted Date
- 2019-09-18
- Last Posted Date
- 2022-07-01
- Lead Sponsor
- University Hospital Heidelberg
- Target Recruit Count
- 28
- Registration Number
- NCT04093505
- Locations
- 🇩🇪
University Hospital Heidelberg, Internal Medicine V, Heidelberg, Baden-Württemberg, Germany
Prostate Cancer Patients Treated With Alternative Radiation Oncology Strategies
Not Applicable
Recruiting
- Conditions
- Prostate Cancer
- Interventions
- Radiation: Hypofractionated radiotherapy with protonsRadiation: Normofractionated radiotherapy with photonsRadiation: Hypofractionated radiotherapy with photons
- First Posted Date
- 2019-09-10
- Last Posted Date
- 2024-01-05
- Lead Sponsor
- University Hospital Heidelberg
- Target Recruit Count
- 897
- Registration Number
- NCT04083937
- Locations
- 🇩🇪
University Hospital Heidelberg, Heidelberg, Germany
Supportive Care With or Without Repeated Whole Brain Radiotherapy in Patients With Recurrent Brain Metastases
Not Applicable
Suspended
- Conditions
- Brain Metastases
- Interventions
- Radiation: RadiationOther: OSC
- First Posted Date
- 2019-09-10
- Last Posted Date
- 2024-01-05
- Lead Sponsor
- University Hospital Heidelberg
- Target Recruit Count
- 40
- Registration Number
- NCT04084431
- Locations
- 🇩🇪
University Hospital, Heidelberg, Germany